{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:45:21Z","timestamp":1791146721798,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T00:00:00Z","timestamp":1313107200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023651","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T20:59:31Z","timestamp":1313182771000},"page":"e23651","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Split T Cell Tolerance against a Self\/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors"],"prefix":"10.1371","volume":"6","author":[{"given":"Takemasa","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Miliotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd J.","family":"Old","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Gnjatic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Multiple roles for CD4+ T cells in anti-tumor immune responses.","volume":"222","author":"R Kennedy","year":"2008","journal-title":"Immunol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","article-title":"The role of CD4+ T cell responses in antitumor immunity.","volume":"10","author":"DM Pardoll","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","article-title":"Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.","volume":"97","author":"E Jager","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1073\/pnas.1133324100","article-title":"Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.","volume":"100","author":"S Gnjatic","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1073\/pnas.0403572101","article-title":"Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.","volume":"101","author":"ID Davis","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1073\/pnas.0703342104","article-title":"Vaccination with an NY-ESO-1 peptide of HLA class I\/II specificities induces integrated humoral and T cell responses in ovarian cancer.","volume":"104","author":"K Odunsi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"20410","DOI":"10.1073\/pnas.0810114105","article-title":"CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.","volume":"105","author":"J Yuan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1073\/pnas.0703395104","article-title":"Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody\/Th1 responses and CD8 T cells through cross-priming.","volume":"104","author":"D Valmori","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1073\/pnas.0707140104","article-title":"Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.","volume":"105","author":"D Atanackovic","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/eji.1830250625","article-title":"Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.","volume":"25","author":"S Gnjatic","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1749-6632.2000.tb06711.x","article-title":"p53: a potential target antigen for immunotherapy of cancer.","volume":"910","author":"R Offringa","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","first-page":"1777","article-title":"p53 Antibodies in the sera of patients with various types of cancer: a review.","volume":"60","author":"T Soussi","year":"2000","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"14704","DOI":"10.1073\/pnas.93.25.14704","article-title":"Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide.","volume":"93","author":"M Ropke","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1073\/pnas.76.5.2420","article-title":"Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.","volume":"76","author":"AB DeLeo","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/278261a0","article-title":"T antigen is bound to a host protein in SV40-transformed cells.","volume":"278","author":"DP Lane","year":"1979","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0092-8674(79)90293-9","article-title":"Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.","volume":"17","author":"DI Linzer","year":"1979","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P","article-title":"Characterization of human colon cancer antigens recognized by autologous antibodies.","volume":"76","author":"MJ Scanlan","year":"1998","journal-title":"Int J Cancer"},{"key":"ref18","first-page":"4041","article-title":"Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.","volume":"62","author":"MJ Scanlan","year":"2002","journal-title":"Cancer Res"},{"key":"ref19","first-page":"4","article-title":"Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.","volume":"1","author":"MJ Scanlan","year":"2001","journal-title":"Cancer Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-60327-811-9_2","article-title":"Autoantibodies against cancer antigens.","volume":"520","author":"S Gnjatic","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1479-5876-3-34","article-title":"Immunologic aspect of ovarian cancer and p53 as tumor antigen.","volume":"3","author":"HW Nijman","year":"2005","journal-title":"J Transl Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4049\/jimmunol.160.1.328","article-title":"Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas.","volume":"160","author":"S Gnjatic","year":"1998","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/ijc.24597","article-title":"Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.","volume":"125","author":"N Leffers","year":"2009","journal-title":"Int J Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/1078-0432.CCR-08-2227","article-title":"Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer.","volume":"15","author":"FM Speetjens","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2008.04.043","article-title":"Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.","volume":"110","author":"N Leffers","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","article-title":"Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.","volume":"97","author":"E Jager","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/MCB.7.2.961","article-title":"Primary structure polymorphism at amino acid residue 72 of human p53.","volume":"7","author":"GJ Matlashewski","year":"1987","journal-title":"Mol Cell Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.4049\/jimmunol.0900903","article-title":"Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.","volume":"183","author":"T Tsuji","year":"2009","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"581939","DOI":"10.1155\/2009\/581939","article-title":"Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.","volume":"2009","author":"B Piura","year":"2009","journal-title":"J Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1349-7006.2007.00501.x","article-title":"Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population.","volume":"98","author":"T Ohkuri","year":"2007","journal-title":"Cancer Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1158\/1078-0432.CCR-05-1900","article-title":"In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.","volume":"12","author":"K Hasegawa","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/1078-0432.CCR-05-0413","article-title":"Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection.","volume":"12","author":"T Soussi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1073\/pnas.91.8.3171","article-title":"A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.","volume":"91","author":"Y Noguchi","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1073\/pnas.92.6.2219","article-title":"Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.","volume":"92","author":"Y Noguchi","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1054\/bjoc.2000.1542","article-title":"Detection of p73 antibodies in patients with various types of cancer: immunological characterization.","volume":"84","author":"O Tominaga","year":"2001","journal-title":"Br J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.4049\/jimmunol.176.10.6340","article-title":"Influence of CD4+CD25+ regulatory T cells on low\/high-avidity CD4+ T cells following peptide vaccination.","volume":"176","author":"H Nishikawa","year":"2006","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2005-02-0607","article-title":"CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.","volume":"106","author":"H Nishikawa","year":"2005","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.4049\/jimmunol.175.9.5765","article-title":"Human CD4+ T cells are predominantly distributed among six phenotypically and functionally distinct subsets.","volume":"175","author":"E Amyes","year":"2005","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1078-0432.CCR-08-1412","article-title":"CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.","volume":"15","author":"RB Sorensen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-05-2013","article-title":"Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.","volume":"12","author":"SJ Antonia","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-007-0293-4","article-title":"Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.","volume":"56","author":"IM Svane","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.185.5.833","article-title":"Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.","volume":"185","author":"M Theobald","year":"1997","journal-title":"J Exp Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1158\/0008-5472.CAN-07-3166","article-title":"Self-tolerance does not restrict the CD4+ T-helper response against the p53 tumor antigen.","volume":"68","author":"MM Lauwen","year":"2008","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.gt.3301709","article-title":"Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man.","volume":"9","author":"J Kuball","year":"2002","journal-title":"Gene Ther"},{"key":"ref45","first-page":"979","article-title":"A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.","volume":"6","author":"M Eura","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-3083.2000.00668.x","article-title":"Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein.","volume":"51","author":"AM Barfoed","year":"2000","journal-title":"Scand J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0198-8859(01)00266-X","article-title":"Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer.","volume":"62","author":"E Ferries","year":"2001","journal-title":"Hum Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.4049\/jimmunol.166.6.3908","article-title":"CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen.","volume":"166","author":"J Hernandez","year":"2001","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hed.21031","article-title":"Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.","volume":"31","author":"AE Albers","year":"2009","journal-title":"Head Neck"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4161\/cc.4.8.1900","article-title":"p53 proteasomal degradation: poly-ubiquitination is not the whole story.","volume":"4","author":"G Asher","year":"2005","journal-title":"Cell Cycle"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/MCB.5.10.2851","article-title":"p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.","volume":"5","author":"A Rogel","year":"1985","journal-title":"Mol Cell Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1089\/hum.2008.083","article-title":"Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.","volume":"19","author":"MR Theoret","year":"2008","journal-title":"Hum Gene Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb06029.x","article-title":"Dendritic cell function in vivo during the steady state: a role in peripheral tolerance.","volume":"987","author":"RM Steinman","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ijc.10375","article-title":"A HLA-A2 restricted human CTL line recognizes a novel tumor cell expressed p53 epitope.","volume":"99","author":"PA Wurtzen","year":"2002","journal-title":"Int J Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1521-4141(200101)31:1<146::AID-IMMU146>3.0.CO;2-T","article-title":"Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.","volume":"31","author":"SH van der Burg","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1073\/pnas.0237083100","article-title":"Nitric oxide-induced cellular stress and p53 activation in chronic inflammation.","volume":"100","author":"LJ Hofseth","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1011-1344(01)00204-4","article-title":"Acute response of human skin to solar radiation: regulation and function of the p53 protein.","volume":"63","author":"D Decraene","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.20715","article-title":"p53 autoantibodies predict subsequent development of cancer.","volume":"114","author":"Y Li","year":"2005","journal-title":"Int J Cancer"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1172\/JCI118874","article-title":"A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.","volume":"98","author":"RI Enelow","year":"1996","journal-title":"J Clin Invest"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.25058","article-title":"NY-CO-58\/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.","volume":"127","author":"S Gnjatic","year":"2010","journal-title":"Int J Cancer"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.","volume":"15","author":"MA Cheever","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T22:16:35Z","timestamp":1712700995000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023651"}},"subtitle":[],"editor":[{"given":"Mauricio Martins","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,12]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023651","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,12]]}}}